Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis

Journal of Oral Pathology and Medicine

Volumn 36, Issue 7, 2007, Pages 415-424

  De Vicente, J C ^a   Lequerica Fernandez P ^a   Santamaria J ^b   Fresno, M F ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Immunohistochemistry; Membrane type I matrix metalloproteinase; MMP 7; Oral squamous cell carcinoma; Prognosis

Indexed keywords

FORMALDEHYDE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; PARAFFIN; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STROMA; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FORECASTING; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34447116989     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00546.x     Document Type: Article

References (40)

1. Zbaren P, Lehmann W. Frequency and sited of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy. Arch Otolaryngol Head Neck Surg 1987 113 : 762 4.
2. Jones LE, Humphreys MJ, Campbell F, Neoptolemos JP, Boyd MT. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004 10 : 2832 45.
3. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996 28 : 123 36.
4. Sires UI, Murphy G, Baragi VM, Fliszar CJ, Welgus HG, Senior RM. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of α1-antitrypsin. Biochem Biophys Res Commun 1994 204 : 613 20.
5. Noe V, Fingleton B, Jacobs K, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001 114 (Pt 1 111 8.
6. Kerkelä E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 2003 12 : 109 25.
7. Miyamoto S, Yano K, Sugimoto S, et al. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res 2004 64 : 665 71.
8. Collier IE, Wilhelm SM, Eisen AZ, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988 263 : 6579 87.
9. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by human normal macrophages. J Biol Chem 1989 264 : 17213 21.
10. Sato H, Takino T, Kinoshita T, et al. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase. A matrix metalloproteinase expressed on the cell surface of invasive tumor cells. Nature 1994 370 : 61 5.
11. Zucker S, Pei D, Cao J, López-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 2003 54 : 1 74.
12. Sabeh F, Ota I, Holmbeck K, et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2005 167 : 769 81.
13. Folgueras AR, Pendás AM, Sánchez LM, López- Otín C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004 48 : 411 24.
14. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999 21 : 627 38.
15. Impola U, Uitto VJ, Hietanen J, et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004 202 : 14 22.
16. Katayama A, Bandoh N, Kishibe K, et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastasis and prognosis. Clin Cancer Res 2004 10 : 634 40.
17. Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 2000 31 : 895 904.
18. Friedrich RE, Giese M, Riethdorf S, Loning T. P53-mutation in smears of oral squamous cell carcinoma. Anticancer Res 2000 20 : 4927 30.
19. van Diest PJ, Brugal G, Baak JPA. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 1998 51 : 716 24.
20. Sobin LH, Witterkind Ch. (eds) TNM classification of malignant tumors. New York : Wiley-Liss, Inc., 1997 17 50.
21. Fidler IJ, Hart IR. Biologic diversity in metastatic neoplasms: origins and implications. Science 1982 217 : 998 1001.
22. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993 71 : 1368 83.
23. Ohashi K, Nemoto T, Nakamura K, Nemori R. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 2000 88 : 2201 9.
24. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002 2 : 163 75.
25. Wolf K, Mazo I, Leung H, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003 160 : 267 77.
26. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003 22 : 145 52.
27. Tan X, Egami H, Abe M, Nozawa F, Hirota M, Ogawa M. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. J Clin Pathol 2000 58 : 1242 8.
28. Xie M, Sun Y, Li Y. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope 2004 114 : 2243 8.
29. Yamashita K, Azumano I, Mai M, Okada Y. Expression of tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinoma. Implication for vessel invasion and metastasis. Int J Cancer 1998 79 : 187 94.
30. O-charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001 127 : 813 20.
31. Chen JQ, Zhan WH, He YL, Cai SR, Peng JS, Chen ZX. Prediction of lymph node metastasis with binary logistic regression in gastric carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 2005 8 : 436 9.
32. Mylona E, Kapranou A, Mavrommatis J, Markaki S, Keramopoulos A, Anakopoulou L. The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer. APMIS 2005 113 : 246 55.
33. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995 81 : 505 12.
34. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996 85 : 817 27.
35. Mitsiades N, Yu W, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 2001 61 : 577 81.
36. Myoung H, Kim MJ, Hong SD, Lee JI, Lim CY, Hong SP. Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma. Cancer Lett 2002 185 : 201 9.
37. Cao J, Chiarelli C, Kozarekar P, Adler HL. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis. Thromb Haemost 2005 93 : 770 8.
38. Yao GY, Yang MT, Rong TH, He P. Significance of membrane type-1 matrix metalloproteinase expression in breast cancer. Ai Zheng 2004 23 (Suppl. 11 1482 6.
39. Sun Y, Wenger L, Rutter JL, Rutter JL, Brinckerhoff CE, Cheung HS. P53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J Biol Chem 1999 274 : 11535 40.
40. Overall CM, López-Otín C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002 2 : 657 72.